The tumor microenvironment is a dominant force in multidrug resistance

Drug Resistance Updates

Volumn 15, Issue 1-2, 2012, Pages 39-49

  Correia, Ana Luísa ^a,b   Bissell, Mina J ^a,c  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF PORTO   (Portugal)

^c NONE   (United States)

Author keywords

Context; Dormancy; Microenvironment; Multidrug resistance; Tumor stroma interactions

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN;

CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL COMMUNICATION; CELL FATE; CELL INTERACTION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STROMA; TUMOR MICROENVIRONMENT;

EID: 84860697028     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2012.01.006     Document Type: Article

References (164)

1. J.A. Aguirre Ghiso, K. Kovalski, and L. Ossowski Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling J. Cell Biol. 147 1999 89 103
2. M. Anders, R. Hansen, R.X. Ding, K.A. Rauen, M.J. Bissell, and W.M. Korn Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor Proc. Natl. Acad. Sci. U.S.A. 100 2003 1943 1948
3. F. Aoudjit, and K. Vuori Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells Oncogene 20 2001 4995 5004
4. M.H. Barcellos-Hoff, J. Aggeler, T.G. Ram, and M.J. Bissell Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane Development 105 1989 223 235
5. J. Bartek, and J. Lukas Mammalian G1- and S-phase checkpoints in response to DNA damage Curr. Opin. Cell Biol. 13 2001 738 747
6. A. Beliveau, J.D. Mott, A. Lo, E.I. Chen, A.A. Koller, and P. Yaswen Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo Genes Dev. 24 2010 2800 2811
7. N.A. Bhowmick, A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, and S. Shappell TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 2004 848 851
8. F.C. Bidard, A. Vincent-Salomon, S. Gomme, C. Nos, Y. de Rycke, and J.P. Thiery Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse Clin. Cancer Res. 14 2008 3306 3311
9. M.J. Bissell The differentiated state of normal and malignant cells or how to define a "normal" cell in culture Int. Rev. Cytol. 70 1981 27 100
10. M.J. Bissell, and H.G. Hall Form and function in the mammary gland: the role of extracellular matrix M.C. Nevell, C.W.D. Neville, The Mammary Gland: Development, Regulation and Function 1987
11. M.J. Bissell, H.G. Hall, and G. Parry How does the extracellular matrix direct gene expression? J. Theor. Biol. 99 1982 31 68
12. M.J. Bissell, and W.C. Hines Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nat. Med. 17 2011 320 329
13. M.J. Bissell, P.A. Kenny, and D.C. Radisky Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes Cold Spring Harb. Symp. Quant. Biol. 70 2005 343 356
14. M.J. Bissell, and D. Radisky Putting tumours in context Nat. Rev. Cancer 1 2001 46 54
15. M.J. Bissell, D.C. Radisky, A. Rizki, V.M. Weaver, and O.W. Petersen The organizing principle: microenvironmental influences in the normal and malignant breast Differentiation 70 2002 537 546
16. P. Bornstein, J. McPherson, and H. Sage Synthesis and secretion of structural macromolecules by endothelial cells in culture Pathobiology of the Endothelial Cell, P and S Biomedical Sciences Symposia 1982
17. N. Boudreau, C.J. Sympson, Z. Werb, and M.J. Bissell Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix Science 267 1995 891 893
18. K.M. Bussard, C.A. Boulanger, B.W. Booth, R.D. Bruno, and G.H. Smith Reprogramming human cancer cells in the mouse mammary gland Cancer Res. 70 2010 6336 6343
19. J.L. Camps, S.M. Chang, T.C. Hsu, M.R. Freeman, S.J. Hong, and H.E. Zhau Fibroblast-mediated acceleration of human epithelial tumor growth in vivo Proc. Natl. Acad. Sci. U.S.A. 87 1990 75 79
20. L. Cao, X. Liu, E.D. Lin, C. Wang, E.Y. Choi, and V. Riban Environmental and genetic activation of a brain-adipocyte BDNF/Leptin axis causes cancer remission and inhibition Cell 142 2010 52 64
21. A.F. Chambers, and L.M. Matrisian Changing views of the role of matrix metalloproteinases in metastasis J. Natl. Cancer Inst. 89 1997 1260 1270
22. G.Z. Cheng, J. Chan, Q. Wang, W. Zhang, C.D. Sun, and L.H. Wang Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel Cancer Res. 67 2007 1979 1987
23. M. Chiquet, L. Gelman, R. Lutz, and S. Maier From mechanotransduction to extracellular matrix gene expression in fibroblasts Biochim. Biophys. Acta 1793 2009 911 920
24. N. Cordes, and V. Meineke Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro Strahlenther Onkol. 179 2003 337 344
25. N. Cordes, and D. van Beuningen Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro Int. J. Radiat. Oncol. Biol. Phys. 58 2004 453 462
26. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
27. G.R. Cunha, S.W. Hayward, Y.Z. Wang, and W.A. Ricke Role of the stromal microenvironment in carcinogenesis of the prostate Int. J. Cancer 107 2003 1 10
28. J.S. Damiano, A.E. Cress, L.A. Hazlehurst, A.A. Shtil, and W.S. Dalton Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines Blood 93 1999 1658 1667
29. C.V. Dang, and G.L. Semenza Oncogenic alterations of metabolism Trends Biochem. Sci. 24 1999 68 72
30. M.T. de la Fuente, B. Casanova, E. Cantero, M. Hernandez del Cerro, J. Garcia-Marco, and A. Silva Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine Biochem. Biophys. Res. Commun. 311 2003 708 712
31. M. Decitre, C. Gleyzal, M. Raccurt, S. Peyrol, E. Aubert-Foucher, and K. Csiszar Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas Lab. Invest. 78 1998 143 151
32. G. Deng, Y. Lu, G. Zlotnikov, A.D. Thor, and H.S. Smith Loss of heterozygosity in normal tissue adjacent to breast carcinomas Science 274 1996 2057 2059
33. A. Di Paolo, and G. Bocci Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification Curr. Oncol. Rep. 9 2007 109 114
34. M. Dimitrijevic-Bussod, V.S. Balzaretti-Maggi, and D.M. Gadbois Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts Cancer Res. 59 1999 4843 4847
35. B. Dirat, L. Bochet, M. Dabek, D. Daviaud, S. Dauvillier, and B. Majed Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion Cancer Res. 71 2011 2455 2465
36. D.E. Discher, P. Janmey, and Y.L. Wang Tissue cells feel and respond to the stiffness of their substrate Science 310 2005 1139 1143
37. D.S. Dolberg, and M.J. Bissell Inability of Rous sarcoma virus to cause sarcomas in the avian embryo Nature 309 1984 552 556
38. D.S. Dolberg, R. Hollingsworth, M. Hertle, and M.J. Bissell Wounding and its role in RSV-mediated tumor formation Science 230 1985 676 678
39. R.E. Durand, and P.L. Olive Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids Methods Cell Biol. 64 2001 211 233
40. R.E. Durand, and R.M. Sutherland Effects of intercellular contact on repair of radiation damage Exp. Cell Res. 71 1972 75 80
41. T. Ebihara, N. Venkatesan, R. Tanaka, and M.S. Ludwig Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Temporal aspects Am. J. Respir. Crit. Care Med. 162 2000 1569 1576
42. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2 2002 161 174
43. C. Flotho, E. Coustan-Smith, D. Pei, C. Cheng, G. Song, and C.H. Pui A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia Blood 110 2007 1271 1277
44. C. Flotho, E. Coustan-Smith, D. Pei, S. Iwamoto, G. Song, and C. Cheng Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2 Blood 108 2006 1050 1057
45. J. Folkman, and R. Kalluri Tumor angiogenesis J.F. Holland, E. Frei III R.C. Bast Jr. D.W. Kufe, R.E. Pollock, R.R. Weichselbaum, Cancer Medicine 6th ed. 2002 PC Decker Inc. Hamilton, Ontario, Canada
46. J. Folkman, and R. Kalluri Cancer without disease Nature 427 2004 787
47. B.A. Frederick, B.A. Helfrich, C.D. Coldren, D. Zheng, D. Chan, and P.A. Bunn Jr. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma Mol. Cancer Ther. 6 2007 1683 1691
48. R. Fridman, G. Giaccone, T. Kanemoto, G.R. Martin, A.F. Gazdar, and J.L. Mulshine Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines Proc. Natl. Acad. Sci. U.S.A. 87 1990 6698 6702
49. S.M. Frisch, and H. Francis Disruption of epithelial cell-matrix interactions induces apoptosis J. Cell Biol. 124 1994 619 626
50. Y. Fu, Z. Fang, Y. Liang, X. Zhu, P. Prins, and Z. Li Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway J. Cell Biochem. 102 2007 704 718
51. B.C. Fuchs, T. Fujii, J.D. Dorfman, J.M. Goodwin, A.X. Zhu, and M. Lanuti Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells Cancer Res. 68 2008 2391 2399
52. S. Goodison, K. Kawai, J. Hihara, P. Jiang, M. Yang, and V. Urquidi Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein Clin. Cancer Res. 9 2003 3808 3814
53. C.H. Graham, H. Kobayashi, K.S. Stankiewicz, S. Man, S.J. Kapitain, and R.S. Kerbel Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents J. Natl. Cancer Inst. 86 1994 975 982
54. T. Gudjonsson, L. Ronnov-Jessen, R. Villadsen, F. Rank, M.J. Bissell, and O.W. Petersen Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition J. Cell Sci. 115 2002 39 50
55. H.R. Harach, K.O. Franssila, and V. Wasenius Occult papillary carcinoma of the thyroid: a "normal" finding in Finland. A systematic autopsy study Cancer 56 1985 531 538
56. N. Hayashi, G.R. Cunha, and Y.C. Wong Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma Cancer Res. 50 1990 4747 4754
57. L.A. Hazlehurst, R.F. Argilagos, and W.S. Dalton Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells Br. J. Haematol. 136 2007 269 275
58. L.A. Hazlehurst, S.A. Enkemann, C.A. Beam, R.F. Argilagos, J. Painter, and K.H. Shain Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model Cancer Res. 63 2003 7900 7906
59. C.H. Heldin, K. Rubin, K. Pietras, and A. Ostman High interstitial fluid pressure - an obstacle in cancer therapy Nat. Rev. Cancer 4 2004 806 813
60. K. Hochedlinger, R. Blelloch, C. Brennan, Y. Yamada, M. Kim, and L. Chin Reprogramming of a melanoma genome by nuclear transplantation Genes Dev. 18 2004 1875 1885
61. A.R. Howlett, N. Bailey, C. Damsky, O.W. Petersen, and M.J. Bissell Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma J. Cell Sci. 108 Pt 5 1995 1945 1957
62. A.R. Howlett, V.C. Carter, G.S. Martin, and M.J. Bissell pp60v-src tyrosine kinase is expressed and active in sarcoma-free avian embryos microinjected with Rous sarcoma virus Proc. Natl. Acad. Sci. U.S.A. 85 1988 7587 7591
63. D.G. Hoyt, M. Rizzo, M.E. Gerritsen, B.R. Pitt, and J.S. Lazo Integrin activation protects pulmonary endothelial cells from the genotoxic effects of bleomycin Am. J. Physiol. 273 1997 L612 L617
64. D. Ingber Integrins as mechanochemical transducers Curr. Opin. Cell Biol. 3 1991 841 848
65. D.E. Ingber Tensegrity: the architectural basis of cellular mechanotransduction Annu. Rev. Physiol. 59 1997 575 599
66. M. Itoh, C.M. Nelson, C.A. Myers, and M.J. Bissell Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells Cancer Res. 67 2007 4759 4766
67. P. Iyengar, V. Espina, T.W. Williams, Y. Lin, D. Berry, and L.A. Jelicks Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment J. Clin. Invest. 115 2005 1163 1176
68. R.K. Jain Delivery of novel therapeutic agents in tumors: physiological barriers and strategies J. Natl. Cancer Inst. 81 1989 570 576
69. R.K. Jain Delivery of molecular and cellular medicine to solid tumors Adv. Drug Deliv. Rev. 46 2001 149 168
70. A. Javaherian, M. Vaccariello, N.E. Fusenig, and J.A. Garlick Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium Cancer Res. 58 1998 2200 2208
71. C.B. Jones, J. McIntosh, H. Huang, A. Graytock, and D.G. Hoyt Regulation of bleomycin-induced DNA breakage and chromatin structure in lung endothelial cells by integrins and poly(ADP-ribose) polymerase Mol. Pharmacol. 59 2001 69 75
72. J.A. Joyce, and J.W. Pollard Microenvironmental regulation of metastasis Nat. Rev. Cancer 9 2009 239 252
73. H. Kajiyama, K. Shibata, M. Terauchi, M. Yamashita, K. Ino, and A. Nawa Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int. J. Oncol. 31 2007 277 283
74. T.G. Karrison, D.J. Ferguson, and P. Meier Dormancy of mammary carcinoma after mastectomy J. Natl. Cancer Inst. 91 1999 80 85
75. P.A. Kenny, and M.J. Bissell Targeting TACE-dependent EGFR ligand shedding in breast cancer J. Clin. Invest. 117 2007 337 345
76. R.S. Kerbel, B. St Croix, V.A. Florenes, and J. Rak Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors Hum. Cell 9 1996 257 264
77. J. Kirshner, C.J. Chen, P. Liu, J. Huang, and J.E. Shively CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture Proc. Natl. Acad. Sci. U.S.A. 100 2003 521 526
78. H. Kobayashi, S. Man, C.H. Graham, S.J. Kapitain, B.A. Teicher, and R.S. Kerbel Acquired multicellular-mediated resistance to alkylating agents in cancer Proc. Natl. Acad. Sci. U.S.A. 90 1993 3294 3298
79. G.E. Konecny, N. Venkatesan, G. Yang, J. Dering, C. Ginther, and R. Finn Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells Br. J. Cancer 98 2008 1076 1084
80. R. Korah, M. Boots, and R. Wieder Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow Cancer Res. 64 2004 4514 4522
81. C.L. Kremer, M. Schmelz, and A.E. Cress Integrin-dependent amplification of the G2 arrest induced by ionizing radiation Prostate 66 2006 88 96
82. M. Krieg, Y. Arboleda-Estudillo, P.H. Puech, J. Kafer, F. Graner, and D.J. Muller Tensile forces govern germ-layer organization in zebrafish Nat. Cell Biol. 10 2008 429 436
83. T.A. Krouskop, T.M. Wheeler, F. Kallel, B.S. Garra, and T. Hall Elastic moduli of breast and prostate tissues under compression Ultrason. Imaging 20 1998 260 274
84. P.M. Kulesa, J.C. Kasemeier-Kulesa, J.M. Teddy, N.V. Margaryan, E.A. Seftor, and R.E. Seftor Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment Proc. Natl. Acad. Sci. U.S.A. 103 2006 3752 3757
85. J.M. Lee, S. Dedhar, R. Kalluri, and E.W. Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease J. Cell Biol. 172 2006 973 981
86. K.R. Levental, H. Yu, L. Kass, J.N. Lakins, M. Egeblad, and J.T. Erler Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 139 2009 891 906
87. H. Liu, D.C. Radisky, F. Wang, and M.J. Bissell Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells J. Cell Biol. 164 2004 603 612
88. T. Lwin, L.A. Hazlehurst, S. Dessureault, R. Lai, W. Bai, and E. Sotomayor Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas Blood 110 2007 1631 1638
89. A.J. Maniotis, C.S. Chen, and D.E. Ingber Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure Proc. Natl. Acad. Sci. U.S.A. 94 1997 849 854
90. A.J. Maniotis, K. Valyi-Nagy, J. Karavitis, J. Moses, V. Boddipali, and Y. Wang Chromatin organization measured by AluI restriction enzyme changes with malignancy and is regulated by the extracellular matrix and the cytoskeleton Am. J. Pathol. 166 2005 1187 1203
91. R.D. Mass, G. Fyfe, J. Hambleton, F. Kabbinavar, H. Hurwitz, and W. Novotny Bevacizumab in combination with 5-FU/leucovorin improves survival in patients with metastatic colorectal cancer: a combined analysis Proc. Am. Soc. Clin. Oncol. 2004 A3616
92. S. Maubant, S. Cruet-Hennequart, L. Poulain, F. Carreiras, F. Sichel, and J. Luis Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line Int. J. Cancer 97 2002 186 194
93. J.A. Menendez, L. Vellon, I. Mehmi, P.K. Teng, D.W. Griggs, and R. Lupu A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway Oncogene 24 2005 761 779
94. H. Miyamoto, T. Murakami, K. Tsuchida, H. Sugino, H. Miyake, and S. Tashiro Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins Pancreas 28 2004 38 44
95. Y. Mori, N. Shimizu, M. Dallas, M. Niewolna, B. Story, and P.J. Williams Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis Blood 104 2004 2149 2154
96. C.J. Morrison, G.S. Butler, D. Rodriguez, and C.M. Overall Matrix metalloproteinase proteomics: substrates, targets, and therapy Curr. Opin. Cell Biol. 21 2009 645 653
97. E.R. Motrescu, and M.C. Rio Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle Biol. Chem. 389 2008 1037 1041
98. J. Muschler, D. Levy, R. Boudreau, M. Henry, K. Campbell, and M.J. Bissell A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells Cancer Res. 62 2002 7102 7109
99. C.A. Myers, C. Schmidhauser, J. Mellentin-Michelotti, G. Fragoso, C.D. Roskelley, and G. Casperson Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation Mol. Cell. Biol. 18 1998 2184 2195
100. G.N. Naumov, I.C. MacDonald, P.M. Weinmeister, N. Kerkvliet, K.V. Nadkarni, and S.M. Wilson Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy Cancer Res. 62 2002 2162 2168
101. G.N. Naumov, J.L. Townson, I.C. MacDonald, S.M. Wilson, V.H. Bramwell, and A.C. Groom Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases Breast Cancer Res. Treat. 82 2003 199 206
102. Y. Nefedova, T.H. Landowski, and W.S. Dalton Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms Leukemia 17 2003 1175 1182
103. C.M. Nelson, and M.J. Bissell Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer Annu. Rev. Cell. Dev. Biol. 22 2006 287 309
104. M. Nielsen, J.L. Thomsen, S. Primdahl, U. Dyreborg, and J.A. Andersen Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies Br. J. Cancer 56 1987 814 819
105. D. Nowak, D. Stewart, and H.P. Koeffler Differentiation therapy of leukemia: 3 decades of development Blood 113 2009 3655 3665
106. A.F. Olumi, G.D. Grossfeld, S.W. Hayward, P.R. Carroll, T.D. Tlsty, and G.R. Cunha Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Res. 59 1999 5002 5011
107. J.W. Orr The changes antecedent to tumour formation during the treatment of mouse skin with carcinogenic hydrocarbons J. Pathol. Bacteriol. 46 1938 495 515
108. T.P. Padera, B.R. Stoll, J.B. Tooredman, D. Capen, E. di Tomaso, and R.K. Jain Pathology: cancer cells compress intratumour vessels Nature 427 2004 695
109. C. Pander Beitrage zur Entwickelungsgeschichte des Huhnchens im Eye 1817 H.L. Bronner Wurzburg
110. K. Pantel, G. Schlimok, S. Braun, D. Kutter, F. Lindemann, and G. Schaller Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells J. Natl. Cancer Inst. 85 1993 1419 1424
111. C.C. Park, H. Zhang, M. Pallavicini, J.W. Gray, F. Baehner, and C.J. Park Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo Cancer Res. 66 2006 1526 1535
112. C.C. Park, H.J. Zhang, E.S. Yao, C.J. Park, and M.J. Bissell Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts Cancer Res. 68 2008 4398 4405
113. M.J. Paszek, N. Zahir, K.R. Johnson, J.N. Lakins, G.I. Rozenberg, and A. Gefen Tensional homeostasis and the malignant phenotype Cancer Cell 8 2005 241 254
114. O.W. Petersen, H.L. Nielsen, T. Gudjonsson, R. Villadsen, F. Rank, and E. Niebuhr Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma Am. J. Pathol. 162 2003 391 402
115. O.W. Petersen, L. Ronnov-Jessen, A.R. Howlett, and M.J. Bissell Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells Proc. Natl. Acad. Sci. U.S.A. 89 1992 9064 9068
116. O. Picard, Y. Rolland, and M.F. Poupon Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases Cancer Res. 46 1986 3290 3294
117. D.B. Plewes, J. Bishop, A. Samani, and J. Sciarretta Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography Phys. Med. Biol. 45 2000 1591 1610
118. L.M. Postovit, E.A. Seftor, R.E. Seftor, and M.J. Hendrix Influence of the microenvironment on melanoma cell fate determination and phenotype Cancer Res. 66 2006 7833 7836
119. D. Radisky, C. Hagios, and M.J. Bissell Tumors are unique organs defined by abnormal signaling and context Semin. Cancer Biol. 11 2001 87 95
120. P. Ricchi, R. Zarrilli, A. Di Palma, and A.M. Acquaviva Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy Br. J. Cancer 88 2003 803 807
121. A.R. Rich Classics in oncology: on the frequency of occurrence of occult carcinoma of the prostate CA. Cancer J. Clin. 29 1979 115 119
122. T. Roose, P.A. Netti, L.L. Munn, Y. Boucher, and R.K. Jain Solid stress generated by spheroid growth estimated using a linear poroelasticity model small star, filled Microvasc. Res. 66 2003 204 212
123. M.L. Salgaller Technology evaluation: bevacizumab, Genentech/Roche Curr. Opin. Mol. Ther. 5 2003 657 667
124. M.S. Samuel, J.I. Lopez, E.J. McGhee, D.R. Croft, D. Strachan, and P. Timpson Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth Cancer Cell 19 2011 776 791
125. T. Sandal, K. Valyi-Nagy, V.A. Spencer, R. Folberg, M.J. Bissell, and A.J. Maniotis Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by AluI restriction enzyme Am. J. Pathol. 170 2007 1739 1749
126. C. Schmidhauser, G.F. Casperson, C.A. Myers, K.T. Sanzo, S. Bolten, and M.J. Bissell A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression Mol. Biol. Cell 3 1992 699 709
127. M. Schmidt, Y. Lu, J.M. Parant, G. Lozano, G. Bacher, and T. Beckers Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies Mol. Pharmacol. 60 2001 900 906
128. J. Schrader, T.T. Gordon-Walker, R.L. Aucott, M. van Deemter, A. Quaas, and S. Walsh Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells Hepatology 53 2011 1192 1205
129. T. Sethi, R.C. Rintoul, S.M. Moore, A.C. MacKinnon, D. Salter, and C. Choo Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo Nat. Med. 5 1999 662 668
130. A.N. Shah, J.M. Summy, J. Zhang, S.I. Park, N.U. Parikh, and G.E. Gallick Development and characterization of gemcitabine-resistant pancreatic tumor cells Ann. Surg. Oncol. 14 2007 3629 3637
131. K.H. Shain, T.H. Landowski, and W.S. Dalton Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines J. Immunol. 168 2002 2544 2553
132. K.H. Shain, D.N. Yarde, M.B. Meads, M. Huang, R. Jove, and L.A. Hazlehurst Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation Cancer Res. 69 2009 1009 1015
133. A.M. Shannon, D.J. Bouchier-Hayes, C.M. Condron, and D. Toomey Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies Cancer Treat. Rev. 29 2003 297 307
134. C.A. Sherman-Baust, A.T. Weeraratna, L.B. Rangel, E.S. Pizer, K.R. Cho, and D.R. Schwartz Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells Cancer Cell 3 2003 377 386
135. M. Skobe, and N.E. Fusenig Tumorigenic conversion of immortal human keratinocytes through stromal cell activation Proc. Natl. Acad. Sci. U.S.A. 95 1998 1050 1055
136. M.D. Sternlicht, A. Lochter, C.J. Sympson, B. Huey, J.P. Rougier, and J.W. Gray The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis Cell 98 1999 137 146
137. W.G. Stetler-Stevenson, and A.E. Yu Proteases in invasion: matrix metalloproteinases Semin. Cancer Biol. 11 2001 143 152
138. A.W. Stoker, C. Hatier, and M.J. Bissell The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia J. Cell Biol. 111 1990 217 228
139. R.M. Sutherland, H.A. Eddy, B. Bareham, K. Reich, and D. Vanantwerp Resistance to adriamycin in multicellular spheroids Int. J. Radiat. Oncol. Biol. Phys. 5 1979 1225 1230
140. C.J. Sympson, R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift, and M.J. Bissell Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression J. Cell Biol. 125 1994 681 693
141. D. Tarin Fine structure of murine mammary tumours: the relationship between epithelium and connective tissue in neoplasms induced by various agents Br. J. Cancer 23 1969 417 425
142. B.A. Teicher, T.S. Herman, S.A. Holden, Y.Y. Wang, M.R. Pfeffer, and J.W. Crawford Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo Science 247 1990 1457 1461
143. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
144. N. Thomasset, A. Lochter, C.J. Sympson, L.R. Lund, D.R. Williams, and O. Behrendtsen Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development Am. J. Pathol. 153 1998 457 467
145. S. Thomson, E. Buck, F. Petti, G. Griffin, E. Brown, and N. Ramnarine Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition Cancer Res. 65 2005 9455 9462
146. J.M. Topczewska, L.M. Postovit, N.V. Margaryan, A. Sam, A.R. Hess, and W.W. Wheaton Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness Nat. Med. 12 2006 925 932
147. J.H. Uhm, N.P. Dooley, A.P. Kyritsis, J.S. Rao, and C.L. Gladson Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death Clin. Cancer Res. 5 1999 1587 1594
148. A. van Stijn, N. Feller, A. Kok, M.A. van der Pol, G.J. Ossenkoppele, and G.J. Schuurhuis Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis Clin. Cancer Res. 11 2005 2540 2546
149. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat. Med. 10 2004 789 799
150. F. Wang, R.K. Hansen, D. Radisky, T. Yoneda, M.H. Barcellos-Hoff, and O.W. Petersen Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts J. Natl. Cancer Inst. 94 2002 1494 1503
151. F. Wang, V.M. Weaver, O.W. Petersen, C.A. Larabell, S. Dedhar, and P. Briand Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology Proc. Natl. Acad. Sci. U.S.A. 95 1998 14821 14826
152. C. Washington, F. Dalbegue, F. Abreo, J.K. Taubenberger, and J.H. Lichy Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas Am. J. Pathol. 157 2000 323 329
153. V.M. Weaver, and M.J. Bissell Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells J. Mammary Gland Biol. Neoplasia 4 1999 193 201
154. V.M. Weaver, A.R. Howlett, B. Langton-Webster, O.W. Petersen, and M.J. Bissell The development of a functionally relevant cell culture model of progressive human breast cancer Semin. Cancer Biol. 6 1995 175 184
155. V.M. Weaver, S. Lelievre, J.N. Lakins, M.A. Chrenek, J.C. Jones, and F. Giancotti beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium Cancer Cell 2 2002 205 216
156. V.M. Weaver, O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, and C. Damsky Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies J. Cell Biol. 137 1997 231 245
157. B. Weigelt, A.T. Lo, C.C. Park, J.W. Gray, and M.J. Bissell HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment Breast Cancer Res. Treat. 122 2010 35 43
158. M.L. Weir, M.L. Oppizzi, M.D. Henry, A. Onishi, K.P. Campbell, and M.J. Bissell Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring J. Cell Sci. 119 2006 4047 4058
159. G. Wiedswang, E. Borgen, R. Karesen, H. Qvist, J. Janbu, and G. Kvalheim Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome Clin. Cancer Res. 10 2004 5342 5348
160. M.A. Wozniak, R. Desai, P.A. Solski, C.J. Der, and P.J. Keely ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix J. Cell Biol. 163 2003 583 595
161. A.D. Yang, F. Fan, E.R. Camp, G. van Buren, W. Liu, and R. Somcio Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines Clin. Cancer Res. 12 2006 4147 4153
162. R.L. Yauch, T. Januario, D.A. Eberhard, G. Cavet, W. Zhu, and L. Fu Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients Clin. Cancer Res. 11 2005 8686 8698
163. T. Yeung, P.C. Georges, L.A. Flanagan, B. Marg, M. Ortiz, and M. Funaki
164. H. Zhang, I. Ozaki, T. Mizuta, S. Matsuhashi, T. Yoshimura, and A. Hisatomi Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway Cancer 95 2002 896 906